Plain-English translation of NCT06866873 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing CD19 cell therapy, a cutting-edge treatment where doctors take your own immune cells, modify them in a laboratory to recognize and attack cancer cells, and then infuse them back into your body. The treatment is designed for children whose blood cancer has come back or stopped responding to previous chemotherapy. Researchers want to understand how safe this medication is and how well it works in children.
Some children's blood cancers stop responding to standard chemotherapy, leaving families with very few options. This trial exists to see if the new treatment can help children in this difficult situation and to make sure the medication is safe for pediatric patients.
You likely qualify if…
You likely don't qualify if…
First, you would receive chemotherapy to prepare your body for the new treatment. Then doctors would collect some of your immune cells through a procedure called leukapheresis. These cells are sent to a laboratory where they are modified over several weeks. Once ready, the engineered cells are infused back into your body intravenously in a single infusion. You would then be closely monitored to see how well the treatment works and to watch for any side effects.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Hong Kong